Skip to main content
Clinical Trials/NCT03985930
NCT03985930
Completed
Not Applicable

Non-immersive Virtual Reality for Pediatric Pain Management

Claudia Aristizábal1 site in 1 country122 target enrollmentNovember 1, 2020
ConditionsProcedural Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Procedural Pain
Sponsor
Claudia Aristizábal
Enrollment
122
Locations
1
Primary Endpoint
LLANTO Pain level: LLANTO pain scale
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This is a multicenter, randomized, clinical trial comparing treatment as usual to distraction with video projection or virtual reality in the management of pediatric (3-6 years) pain associated with venipuncture, intramuscular injection, and vaccination.

Detailed Description

Background: Recent studies have shown that the use of virtual reality (VR) may be useful to provide distraction that attenuates pain in minimally invasive procedures in preschool children. Aim: To assess the effectiveness of non-immersive virtual reality as a pain-distraction measure in children between the ages of 3 to 5 years undergoing painful injection procedures in an outpatient setting. Method: This clinical trial will recruit patients under 6 years of age treated at participating medical centers in whom a painful procedure like vaccination, venipuncture or administration of intramuscular medication will be performed. The experimental group will consist of two subgroups which, in addition to treatment as usual, will be distracted using virtual reality content delivered through goggles. The control group will receive treatment as usual. The LLANTO pain scale will be used to measure different characteristics of pain. This scale has been validated in Colombia, and will be filled by two health professionals (one of which will perform the painful procedure.) and the parents. Expected results: To show that virtual reality or projector distraction are effective distraction tools in pain management for children subjected to painful procedures of venipuncture, intramuscular medication administration, and vaccination.

Registry
clinicaltrials.gov
Start Date
November 1, 2020
End Date
December 1, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Claudia Aristizábal
Responsible Party
Sponsor Investigator
Principal Investigator

Claudia Aristizábal

Coordinadora Unidad de Investigación

Sanitas University

Eligibility Criteria

Inclusion Criteria

  • Patients subjected to procedures of venipuncture, intramuscular injections, or vaccination at participating medical centers.

Exclusion Criteria

  • Fever (Axillary temperature greater than 38°C).
  • Systemic Inflammatory Response Syndrome or Sepsis.
  • Pulmonary disease.
  • Neurological deficit of any kind.
  • Susspected or confirmed metabolic disease.
  • Undernutrition or obesity as defined by deviations from the mean of local values.

Outcomes

Primary Outcomes

LLANTO Pain level: LLANTO pain scale

Time Frame: Immediately after procedure

Overall pain assessment using the LLANTO pain scale (Mild: 0-3, Moderate 4-6, Intense 7-10) For more information about LLANTO scale, please visit DOI: 10.1016/j.anpedi.2010.08.005

Secondary Outcomes

  • LLANTO Attitude(Immediately after procedure)
  • LLANTO Postural muscle tone(Immediately after procedure)
  • Interrater reliability of the LLANTO scale(During the statistical analysis stage)
  • LLANTO Crying(Immediately after procedure)
  • LLANTO Breathing(Immediately after procedure)
  • LLANTO Facial expression(Immediately after procedure)

Study Sites (1)

Loading locations...

Similar Trials